Boehringer Ingelheim
  • Therapeutic Area
    • Metabolic
    • Cardiovascular
    • Oncology
    • Respiratory
  • Resources
  • Contact
th
Login

 

Resources

VIDEOS

What is the leading cause of death in patients with type 2 diabetes?

01:25

What is the leading cause of death in patients with type 2 diabetes?
Are patients with T2D at elevated CV risk?

02:11

Are patients with T2D at elevated CV risk?
What are the main considerations when choosing a medication for patients with type 2 diabetes?

02:15

What are the main considerations when choosing a medication for patients with type 2 diabetes?
Asian CardioDiabetes Forum 2018 - Why is it important to examine evidence and not assume class effect by Prof. Richard Donnelly

02:40

Asian CardioDiabetes Forum 2018 - Why is it important to examine evidence and not assume class effect by Prof. Richard Donnelly
Asian CardioDiabetes Forum 2018 - How have recent CV outcome trials influence clinical practice by Dr. Neale Cohen

04:05

Asian CardioDiabetes Forum 2018 - How have recent CV outcome trials influence clinical practice by Dr. Neale Cohen
Asian CardioDiabetes Forum 2018 - The role of a cardiologist in diabetes management by Dr. Mansoor Husain

04:12

Asian CardioDiabetes Forum 2018 - The role of a cardiologist in diabetes management by Dr. Mansoor Husain
Life happens: How emergency situations affect life of patients on OAC treatment

00:53

Life happens: How emergency situations affect life of patients on OAC treatment
Life happens: Appendicitis is one of the most frequent abdominal surgical emergencies

00:51

Life happens: Appendicitis is one of the most frequent abdominal surgical emergencies
Optimising outcomes in EGFR mutation-positive NSCLC: which tyrosine kinase inhibitor and when?

01:24

Optimising outcomes in EGFR mutation-positive NSCLC: which tyrosine kinase inhibitor and when?
Early intervention to optimize lung function

02:14

Early intervention to optimize lung function
New GOLD recommendations: ICS usage and eosinophil count as biomarker

02:17

New GOLD recommendations: ICS usage and eosinophil count as biomarker
GOLD Update 2019 Guidelines

08:30

GOLD Update 2019 Guidelines
New GOLD recommendations: Role of LABA/LAMA combinations in COPD.

01:49

New GOLD recommendations: Role of LABA/LAMA combinations in COPD
Load more
  • Therapeutic Area
  • Metabolic
  • Cardiovascular
  • Oncology
  • Respiratory
  • Resources
  • Videos
  • Clinical studies
  • Site map
  • Terms of use
  • Privacy
  • Contact
  • Change country

Copyright © 2021 Boehringer Ingelheim (Thai) Ltd.
All rights reserved. Use of this Site is subject to the Terms of Use and Privacy Statement.

This website is intended for healthcare professionals in Thailand. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.